Skip to content
★ Sign in to follow
BC
Total declarations
81
Company
1
▲ Purchases (80 ops.)
€349k
▼ Sales (0 ops.)
—

Latest filing published 25 Mar 2013 for ClearPoint Neuro, Inc., €2,867.

Insider track record

Disclosed buys
80
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
80
Positive at T+90
14%
Median T+90
-24.7%

Based on 59 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 25 Mar 2013 · 4976 days ago · €2,867
    +5.9%
    Entry US$47.20 · Close at T+365 US$50.00
  • Filed 21 Mar 2013 · 4980 days ago · €2,682
    -7.7%
    Entry US$52.00 · Close at T+365 US$48.00
  • Filed 18 Mar 2013 · 4983 days ago · €5,788
    -13.3%
    Entry US$60.00 · Close at T+365 US$52.00
  • Filed 14 Mar 2013 · 4987 days ago · €2,302
    -12.8%
    Entry US$59.60 · Close at T+365 US$52.00
  • Filed 12 Mar 2013 · 4989 days ago · €6,027
    -16.0%
    Entry US$60.00 · Close at T+365 US$50.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Bruce C. Conway: trading record in brief

Bruce C. Conway appears in our data through filings on ClearPoint Neuro, Inc. shares, published by SEC (Form 4). The record holds 81 filings, for trades running from 25 May 2012 to 22 March 2013.

Every open-market trade on record is a purchase: 80 purchases worth €349k, and no sale. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. In 2013 alone, the filings show 16 purchases and no sales.

Half of the purchases are above €3,929 and half below. Looking at 59 purchases old enough to measure, the stock rose over the following 90 days in 14% of cases; the median change was -24.7%. This is a record of the past, not a forecast.

The newest entry dates from 25 March 2013: an open-market purchase of €2,867, in ClearPoint Neuro, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Bruce C. Conway

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations62 total

25 of 62 declarations